377 related articles for article (PubMed ID: 24417680)
1. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations.
Trnka H; Rantanen J; Grohganz H
Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680
[TBL] [Abstract][Full Text] [Related]
2. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared imaging for high-throughput screening of moisture induced changes in freeze-dried formulations.
Trnka H; Palou A; Panouillot PE; Kauppinen A; Toiviainen M; Grohganz H; Alcalà M; Juuti M; Ketolainen J; Rantanen J
J Pharm Sci; 2014 Sep; 103(9):2839-2846. PubMed ID: 24665039
[TBL] [Abstract][Full Text] [Related]
4. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
5. Crystallizing amino acids as bulking agents in freeze-drying.
Horn J; Tolardo E; Fissore D; Friess W
Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
[TBL] [Abstract][Full Text] [Related]
6. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
[TBL] [Abstract][Full Text] [Related]
7. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
8. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
9. Screening of novel excipients for freeze-dried protein formulations.
Holm TP; Meng-Lund H; Rantanen J; Jorgensen L; Grohganz H
Eur J Pharm Biopharm; 2021 Mar; 160():55-64. PubMed ID: 33508435
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
[TBL] [Abstract][Full Text] [Related]
11. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389
[TBL] [Abstract][Full Text] [Related]
12. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
Lueckel B; Bodmer D; Helk B; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
[TBL] [Abstract][Full Text] [Related]
13. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
Al-Hussein A; Gieseler H
J Pharm Sci; 2012 Jul; 101(7):2534-44. PubMed ID: 22535541
[TBL] [Abstract][Full Text] [Related]
14. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
[TBL] [Abstract][Full Text] [Related]
15. Fuzzy Logic-based expert system for evaluating cake quality of freeze-dried formulations.
Trnka H; Wu JX; Van De Weert M; Grohganz H; Rantanen J
J Pharm Sci; 2013 Dec; 102(12):4364-74. PubMed ID: 24258283
[TBL] [Abstract][Full Text] [Related]
16. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents.
Wittaya-Areekul S; Nail SL
J Pharm Sci; 1998 Apr; 87(4):491-5. PubMed ID: 9548903
[TBL] [Abstract][Full Text] [Related]
17. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
J Pharm Sci; 2020 Jan; 109(1):807-817. PubMed ID: 31622600
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers.
De Beer TR; Wiggenhorn M; Hawe A; Kasper JC; Almeida A; Quinten T; Friess W; Winter G; Vervaet C; Remon JP
Talanta; 2011 Feb; 83(5):1623-33. PubMed ID: 21238761
[TBL] [Abstract][Full Text] [Related]
19. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
Martini A; Kume S; Crivellente M; Artico R
PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035
[TBL] [Abstract][Full Text] [Related]
20. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]